However, a previous study found no differences in circulating levels of bradykinin and kallidin peptides, and low molecular weight kininogens, or in plasma kallikrein or kallistatin although plasma TK levels were higher in subjects with type 2 diabetes. Here, KLK4 is linked to type 2 diabetes mellitus.